Paragon 28, Inc. USDC – District of Colorado October 2, 2024 CLASS PERIOD: may 5, 2023 – august 8, 2024LEAD PLAINTIFF DEADLINE: november 29, 2024 Join Investigation Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Paragon 28, Inc. (FNA) – Deadline is November 29, 2024 Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon” or the “Company”) (NYSE: FNA) securities between May 5, 2023 and August 8, 2024 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Paragon and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than November 29, 2024 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. On July 30, 2024, after market hours, Paragon disclosed in a filing with the Securities and Exchange Commission (“SEC”) that the Company’s previously issued financial statements for certain quarterly periods in 2023 and 2024 should no longer be relied upon “due to errors in such financial statements” and that a restatement of these prior financial statements is required. Paragon also disclosed that it had “identified errors in the accounting for inventory including the calculation of its excess and obsolete inventory reserve which resulted in an overstatement of inventory as of March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024 and an understatement in cost of goods sold for the respective interim periods ended on such dates and for the fiscal year ended December 31, 2023.” Additionally, the Company stated that as a result of the errors and the related restatement, it had identified “one or more material weaknesses in its internal control over financial reporting.” Following this news, the price of Paragon fell $1.24 per share, or 13.73%, to close at $7.79 per share on July 31, 2024. Then, on August 8, 2024, after the market closed, Paragon issued restated financials in SEC filings to correct the previously disclosed errors in “the calculation of excess and obsolete inventory, as well as its accounting for inventory variances. . . .” On this news, the price of Paragon fell $1.67 per share, or 20%, to close at $6.64 per share on August 9, 2024. The complaint alleges, among other things, that throughout the Class Period, the Defendants failed to disclose to investors: (i) Paragon 28’s financial statements were misstated; (ii) Paragon 28 lacked adequate internal controls and at times understated the extent of the issues with its internal controls; and (iii) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us MediaAlpha, Inc. See the Case PACS Group, Inc. See the Case WM Technology See the Case Humacyte, Inc. See the Case Acadia Healthcare Company, Inc. See the Case Edwards Lifesciences Corporation See the Case United Parcel Service, Inc. See the Case Elanco Animal Health Incorporated See the Case Iris Energy Ltd See the Case Toronto-Dominion Bank See the Case Fluence Energy, Inc. See the Case Light & Wonder, Inc. See the Case